SCV-07

DRUG4 trials

Sponsors

SciClone Pharmaceuticals

Conditions

Chronic Hepatitis CHead and Neck CancerOral Mucositis

Phase 2

Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer

CompletedNCT00756951

SciClone PharmaceuticalsHead and Neck Cancer, Oral Mucositis

Start: 2008-09-30Target: 59Updated: 2009-11-23

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

CompletedNCT00968357

SciClone PharmaceuticalsChronic Hepatitis C

Start: 2009-09-30End: 2011-01-31Updated: 2012-06-08

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone PharmaceuticalsOral Mucositis

Start: 2010-12-31End: 2014-06-30Target: 160Updated: 2014-05-26

Unknown Phase

Extension Study SCI-SCV-HCV-P2-001: Long-Term FU in Subj Who Opt for Retreatment With Peg-INF and RBV After Completing Treatment in HCV

CompletedNCT01310205

SciClone PharmaceuticalsChronic Hepatitis C

Start: 2010-08-31End: 2012-03-31Updated: 2012-03-08